- Research Article
- 10.1055/s-0046-1818851
Utility of Anterior Clinoidectomy in Neck Clipping for Reccurent Aneurysms After Coil Embolization
- Feb 27, 2026
- Journal of Neurological Surgery Part B: Skull Base
- Yamaoka Hiroto + 1 more +1
Publications from 2021 to 2026
Showing 10 of 50 papers
Utility of Anterior Clinoidectomy in Neck Clipping for Reccurent Aneurysms After Coil Embolization
Outcomes of Mini-Endoscopic Combined Intrarenal Surgery in the Geriatric Population: A Matched-Pair Analysis.
To investigate the safety and efficacy of mini-endoscopic combined intrarenal surgery (ECIRS) in older patients with renal and ureteral stones. Consecutive patients with renal or ureteral stones who underwent mini-ECIRS were retrospectively analyzed at three Japanese tertiary care institutions between 2015 and 2021. Data on patient backgrounds, stone characteristics, and postoperative indications were collected and evaluated. After matching preoperative and intraoperative factors in older patients and other groups, postoperative factors were assessed using univariate analysis. The final analysis included data from 1303 single-session mini-ECIRS of 1432 cases collected. The patients were divided into two groups: those aged > 75 and those aged < 75 years, with 121 and 1182 patients. From each group, 112 cases matched for eight factors, performance status, body mass index, sex, hydronephrosis, percutaneous nephrostomy, pyuria, preoperative urinary tract infection, and preoperative ureteral stenting, were selected. The univariate analysis was performed on postoperative factors between the groups of matched older and matched non-older patients, and there was no significant difference in any factor, including postoperative hospitalization duration, complications, and stone-free rate (SFR). To the best of our knowledge, this multicenter cohort study is the first to compare the efficacy and safety of the mini-ECIRS between older patients and other groups. It was discovered that surgery could be performed with a similar quality even in patients aged 75 and older compared to that in other groups.
Read moreImprovement in Gait Variability over 24 Months in an Individual with Hemiparesis following Stroke: A Case Report.
Gait variability, related to gait stability, is crucial because it is associated with the risk of falls in patients with hemiparesis following stroke. However, there is a lack of understanding regarding changes in gait variability over time in patients with stroke. This case report aimed to describe the improvement in gait variability over 24 months in an individual with hemiparesis following stroke. A 34-year-old man was admitted to the hospital with a diagnosis of cerebral infarction due to atherosclerosis. The patient presented with severe motor paralysis of the right extremities, scoring 6 and 13 on the Fugl-Meyer Assessment for the upper and lower extremities, respectively. Data collection for patient examination started at 1 month post-stroke. Two measures were employed for quantifying gait variability: the Gait Variability Index (GVI) and the coefficient of variation (CV). Nine spatiotemporal parameters were collected for calculating the GVI and CV. The patient was discharged after 5 months post-stroke. At 24 months, he was able to walk independently outdoors without using a cane or an ankle-foot orthosis. Improvements in the GVI and CV were observed during the first 4 months following stroke; however, no marked changes were noted thereafter. At 24 months, the CV for step length, single support time, and swing time demonstrated the most marked improvements. Gait variability in this patient showed the most improvement during the subacute phase. Additionally, improvement in gait variability may be the basis for achieving independent walking, and future research is warranted.
Read moreIncidence of Malignancy in Post-Donation Living Kidney Donors: A Single-Center, Retrospective Cohort Study in Japan.
Long-term health outcomes in living kidney donors (LKDs) are generally favourable. However, recent studies suggest a slightly increased malignancy risk when compared to the general healthy population. Malignancies are influenced by environmental and racial factors; nonetheless, descriptive epidemiological studies on malignancy incidence in LKDs in Asia are lacking. In this study, we aimed to investigate the incidence and characteristics of post-donation malignancies in LKDs. This retrospective observational study included 196 LKDs who underwent nephrectomies between 2008 and 2023. LKDs were categorised into new-onset malignancy and non-malignancy cohorts. Postoperative malignancy surveillance combined population-based cancer screenings, employer-sponsored health examinations, self-paid health checkups, and active surveillance. Baseline characteristics, cancer types, outcomes, and the correlation between cancer incidence and postoperative albuminuria were analysed. Eighteen LKDs (9.2%) developed malignancies over a mean follow-up of 6.7 ± 4.1 years, with an incidence rate of 13.6 per 1000 person-years. The most common cancers were gastric, colorectal, and prostate. Malignancy was more frequent in older donors, males, and those with postoperative hypertension. Most cases were detected at an early stage, allowing curative treatment. The most common diagnostic category of cancer identified was performed as part of our institution's active surveillance. No notable correlation was observed between albuminuria and cancer incidence. While some LKDs developed post-donation malignancies, appropriate and balanced cancer surveillance is essential in managing LKDs, in whom the principle of "do no harm" must be upheld. Establishing a structured system, including public screening programmes and LKD-specific surveillance, would help ensure donor safety and long-term health.
Read moreRupture of the Ulnar Artery in a Case of Neurofibromatosis Type 1.
Neurofibromatosis type 1 (NF1) is a genetic disorder involving an abnormality on chromosome 17, resulting in the production of the protein neurofibromin. Neurofibromin inhibits cell proliferation, and abnormalities in its encoding gene are hypothesized to trigger signals for proliferation, resulting in various lesions. Vascular fragility is a rare complication of NF1; however, ruptures of various vessels have also been reported. Here, we present a case of ulnar artery rupture treated endovascularly by puncturing the ipsilateral brachial artery, achieving excellent results.
Read moreEvaluation of Candidates for Upfront Docetaxel Therapy Among Patients With Metastatic Castration-sensitive Prostate Cancer from a Retrospective Multicenter Study (MAHOROBA study).
It remains unclear whether patients with metastatic castration-sensitive prostate cancer (mCSPC) are suitable for upfront docetaxel therapy. Therefore, we retrospectively evaluated patients with metastatic castration-resistant prostate cancer (mCRPC) who could not receive ≥6 cycles of docetaxel for mCRPC. This study enrolled 274 patients diagnosed with mCSPC who later developed mCRPC, with data at diagnosis, including blood test results, available from 17 hospitals between 2008 and 2022. Failure to receive ≥6 cycles of docetaxel was defined as receiving ≤5 cycles of docetaxel for mCRPC or dying due to prostate cancer without docetaxel therapy. Factors at mCSPC diagnosis associated with failure to receive ≥6 cycles of docetaxel were evaluated using logistic regression analysis. Ninety-three patients were not able to receive ≥6 cycles of docetaxel for mCRPC. Multivariate analysis revealed that high lactate dehydrogenase levels and Gleason grade group 5 were significantly associated with failure receive ≥6 cycles of docetaxel for mCRPC. Furthermore, in patients with these factors at mCSPC diagnosis, receiving ≥6 cycles of docetaxel was significantly associated with better overall survival. Patients with mCSPC who have high lactate dehydrogenase levels and a Gleason grade 5 may be candidates for upfront docetaxel therapy, as they may otherwise miss the chance to receive adequate doses for prostate cancer.
Read moreAn autopsy case of spinal bulbar muscular atrophy concomitant with multiple system atrophy pathology
We describe an autopsy case of spinal bulbar muscular atrophy (SBMA) concomitant with multiple system atrophy (MSA). A Japanese male patient developed gait disturbance in his twenties. His brother and niece also presented with similar clinical symptoms. His condition gradually worsened, and he became immobile at the age of 50 years. Genetic analysis revealed the expansion of CAG repeats of the SBMA gene. At 63 years of age, cerebellar ataxia symptoms emerged. Magnetic resonance images of the head showed a "hot cross bun sign" at the pontine basis and bilateral atrophy of the middle cerebellar peduncles and cerebellar hemispheres, suggesting MSA. He died of pneumonia at the age of 65 years, with a clinical illness of approximately 40 years. The neuropathological diagnosis was consistent with both SBMA and MSA. Neurons of the spinal anterior horn and brainstem motor nuclei were diminished. 1C2 (polyglutamine) immunoreactive intranuclear and intracytoplasmic inclusions were observed in the neurons in the substantia nigra, brainstem tegmentum, pontine nuclei, spinal anterior horn cells and Onuf's nucleus. These findings were suggestive of SBMA. Meanwhile, neurons of the inferior olivary nuclei, pontine nuclei, and Purkinje cells were nearly completely lost. The cerebellar white matter, pontine basis, and middle cerebellar peduncles showed a prominent loss of fibers. α-synuclein positive glial cytoplasmic inclusions were observed in widespread areas. These findings were suggestive of MSA. To the best of our knowledge, another case of SBMA accompanying MSA, similar to the present case, have been reported to date. Moreover, several cases of pathologically proven amyotrophic lateral sclerosis and MSA have been reported. The development of molecular biological techniques and accumulation of pathologically diagnosed patients may reveal common pathological mechanisms in SBMA and MSA.
Read moreThe randomized study of enteral nutrition with rapid versus conventional administration in acute stroke patients; the protocol of rapid EN trial.
Enteral nutrition is beneficial for stroke patients with oral intake difficulties. However, it is time consuming and may interfere with routine medical care. Therefore, there is a clinical benefit if enteral nutrition can be safely administered in a short time. Although our retrospective study showed the safety of rapid administration, it remains unclear whether rapid administration of enteral nutrition is as safe as conventional administration. The randomized study of Enteral Nutrition with Rapid versus conventional administration in acute stroke patients (Rapid EN trial) aims to clarify the safety of rapid feeding of enteral nutrition compared with conventional feeding. This is an investigator-initiated, multicenter, prospective, randomized, open-label, blinded end-point clinical trial. Eligible criteria include acute stroke patients who have difficulty with oral intake defined as severe altered consciousness (Japan Coma Scale 10-300) or modified water swallowing test <4. The target enrollment is 700 patients, with 350 patients receiving rapid enteral nutrition at a rate of 100 mL in 5 min (Rapid EN group) and 350 patients receiving conventional enteral nutrition at a rate of 100 mL in 30 min (Conventional EN group). The primary outcome is the incidence of one or more complications of vomiting or diarrhea or pneumonia within 7 days would be non-inferior in the rapid EN group compared to the conventional EN group. Secondary outcomes were total time spent on enteral nutrition within 7 days from enteral nutrition, the incidence of vomiting, diarrhea and pneumonia within 3 or 7 days, and the rate of favorable clinical outcome. Since no previous reports have focused on the speed of administration, we felt it was necessary to prove the safety of rapid administration. If this study shows positive results, it will not only benefit patients, but also reduce the burden of medical care. We believe this study is novel and will be useful in clinical practice. https://rctportal.niph.go.jp/s/detail/um?trial_id=UMIN000046610 Identifier UMIN000046610.
Read moreFactors associated with cavity formation after stereotactic body radiation therapy for peripheral early-stage lung cancer.
This retrospective study aimed to identify the factors associated with cavity formation after SBRT in peripheral early-stage lung cancer patients. We analyzed the occurrence of cavity changes after SBRT. We examined 99 cases with T1-T2aN0 peripheral non-small cell lung cancer treated with SBRT from 2004 to 2021. Patients underwent respiratory function tests, including diffusing capacity for carbon monoxide (DLco), before treatment. The median observation period was 35months (IQR 18-47.5months). Treatment involved fixed multi-portal irradiation in 67% of cases and VMAT in 33%. The total radiation doses ranged from 42 to 55Gy, delivered over 4 to 5 fractions. Cavity formation occurred in 14 cases (14.1%), appearing a median of 8months after SBRT. The cavity disappeared in a median of 4months after formation. High DLco and total radiation dose were identified as factors significantly associated with cavity formation. There have been no confirmed recurrences to date, but one patient developed a lung abscess. Although cavity formation after SBRT for peripheral early-stage lung cancer is infrequent, it can occur. This study showed high DLco and total radiation dose to be factors significantly associated with cavity formation. These findings can be applied to optimizing radiation therapy (RT) and improving patient outcomes. Further research is needed to determine the optimal radiation dose for patients with near-normal DLco for whom surgery is an option. This study provides valuable insights into image changes after RT.
Read moreMediastinal hematoma due to traumatic injury to the azygous vein
Key Clinical MessageRupture of the azygous vein may result from abrupt deceleration applied to the mobile azygous arch, which can initiate shearing forces within the thorax.
Read more